InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-8.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Kotzin Brian L., Director. Insider active across 4 companies, notably RIGEL PHARMACEUTICALS INC. In total, 11 disclosures have been logged. Activity tracked since 19 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
12,500 shares0Common StockSEC:0000950170-24-069927:0
25,000 shares0Common StockSEC:0000905148-24-001653:0
25,000 shares0Common StockSEC:0001140361-23-034283:0
12,500 shares0Common StockSEC:0000950170-23-028599:0
44 sharesSeries X Preferred StockSEC:0000899243-23-000970:0
96,154 shares0Common StockSEC:0000899243-22-023092:0
25,000 shares0Common StockSEC:0001140361-22-020302:0
29,183 shares0Common StockSEC:0000899243-21-024206
29,183 shares0Common StockSEC:0000899243-21-024206:0
25,000 shares0Common StockSEC:0001179110-21-005768
25,000 shares0Common StockSEC:0001179110-21-005768:0
11 of 11 declarations
About Kotzin Brian L.
Brian L. Kotzin is a Board Member at Rigel Pharmaceuticals Inc and Progenity, Inc., where he contributes to the governance and strategic direction of the companies. As a board member, he is involved in important decision-making and overseeing operations. His experience in the pharmaceutical sector is a valuable asset.
